Document is current
Any future updates will be listed below
-
Authors
Lafrance-Vanasse, Julien https://orcid.org/0000-0001-8807-6277
Sadekar, Shraddha S.
Yang, Yanli
Yadav, Daniela Bumbaca
Meilandt, William J.
Wetzel-Smith, Monica K.
Cai, Hao
Crowell, Susan R.
Nguyen, Van
Lee, Vivian
Chih, Ben https://orcid.org/0000-0002-1248-8379
Kwong, Mandy
Chan, Pamela
Santagostino, Sara
Lee, Donna https://orcid.org/0000-0003-1061-1385
Chung, Shan https://orcid.org/0000-0002-5494-2103
Lazar, Greg A. https://orcid.org/0000-0003-2169-8703
Ernst, James A.
Atwal, Jasvinder K. https://orcid.org/0000-0001-5995-478X
-
Funding
Funding for this research was provided by:
Genentech (N/A)
- License Information
-
More Information
Article History
Received: 26 February 2024
Accepted: 23 April 2025
First Online: 3 May 2025
Competing interests
: J.L.-V., S.S.S., Y.Y., D.B.Y., W.J.M., M.K.W.-S., H.C., S.R.C., V.N., V.L., B.C., M.K., P.C., S.S., D.L., S.C., G.A.L., J.A.E., J.K.A. are or were employees of Genentech Inc., a member of the Roche Group, and may hold Roche stock or related interests. S.S.S., Y.Y., S.C., G.A.L., J.A.E., J.K.A. are inventors on WO/2020/132230 and U.S. Pub. No. US20220033520A1 entitled “Modified antibody fcs and methods of use”.
